Stay updated on Pembrolizumab and Radiotherapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page is updated to reflect a new ClinicalTrials.gov interface/release revision number (from v3.5.2 to v3.5.3). This represents a site maintenance/version change rather than a change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-26T15:38:55.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T14:01:50.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T20:20:12.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3; no visible changes to the study details or page layout.
    Difference
    0.1%
    Check dated 2026-03-07T06:38:07.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision history updated for study documents: added revision v3.4.2 and removed v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-13T14:43:35.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Added document revision tag v3.4.1 and removed v3.4.0; these are metadata updates that do not affect the study details, eligibility criteria, or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:25:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Radiotherapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.